Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACET | BMY | AMGN | GILD | REGN |
| Company | Adicet Bio Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8900 | 47.39 | 273.45 | 67.47 | 911.09 |
| High | 1.9500 | 47.50 | 274.35 | 67.90 | 915.00 |
| Low | 1.8050 | 44.37 | 267.24 | 65.09 | 876.75 |
| Last | 1.8000 | 44.69 | 267.35 | 65.00 | 889.00 |
| Change | -0.0800 | -4.17 | -5.66 | -2.08 | -17.54 |
| % Change | -4.26% | -8.53% | -2.07% | -3.10% | -1.93% |
| Volume | 744,910 | 40,237,490 | 1,192,450 | 11,564,807 | 417,427 |
| 20-Day Average Volume | 670,781 | 12,460,531 | 2,112,438 | 6,589,949 | 444,646 |
| Previous Close | 1.8750 | 48.86 | 273.01 | 67.08 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.1683 | 49.94 | 270.73 | 68.68 | 922.58 |
| 20-Day Raw Stochastic | 5.56% | 4.11% | 33.17% | 0.58% | 16.37% |
| 20-Day Relative Strength | 38.98% | 28.49% | 45.28% | 28.27% | 35.33% |
| Weighted Alpha | -55.27 | -34.57 | +9.43 | -23.76 | +11.37 |
| Today's Opinion | 24% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 24% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 24% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.38% since 04/18/24 | -7.28% since 04/18/24 | +2.73% since 04/18/24 | -1.38% since 04/18/24 | -0.21% since 04/18/24 |
| Low | 1.8000 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 876.75 on 04/25/24 |
| High | 2.2500 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -16.59% since 03/25/24 | -14.29% since 03/25/24 | -3.88% since 03/25/24 | -10.10% since 03/25/24 | -7.17% since 03/25/24 |
| Low | 1.8000 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 876.75 on 04/25/24 |
| High | 2.4300 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -25.71% since 01/25/24 | -9.73% since 01/25/24 | -13.00% since 01/25/24 | -18.67% since 01/25/24 | -5.98% since 01/25/24 |
| Low | 1.8000 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 876.75 on 04/25/24 |
| High | 3.6200 on 02/06/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +50.41% since 10/25/23 | -20.89% since 10/25/23 | -0.82% since 10/25/23 | -16.76% since 10/25/23 | +11.93% since 10/25/23 |
| Low | 1.1000 on 11/29/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.20 on 04/25/24 | 769.19 on 10/27/23 |
| High | 3.7700 on 01/09/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 154,069 | 99,027,448 | 146,436,016 | 83,519,768 | 99,503,640 |
| Shares Outstanding, K | 82,170 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -142,660,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -29,490,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.88 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 03/19/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 09/21/18 | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 24.14 |